Cart
sales@molnova.com
H-Gly-Arg-Ala-Asp-Ser-Pro-OH
CAS No. 99896-86-3
H-Gly-Arg-Ala-Asp-Ser-Pro-OH( ——— )
Catalog No. M39933 CAS No. 99896-86-3
H-Gly-Arg-Ala-Asp-Ser-Pro-OH (GRADSP) is a negative control peptide of GRGDdSP.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 109 | In Stock |
|
| 10MG | 180 | In Stock |
|
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameH-Gly-Arg-Ala-Asp-Ser-Pro-OH
-
NoteResearch use only, not for human use.
-
Brief DescriptionH-Gly-Arg-Ala-Asp-Ser-Pro-OH (GRADSP) is a negative control peptide of GRGDdSP.
-
DescriptionH-Gly-Arg-Ala-Asp-Ser-Pro-OH (GRADSP) is a negative control peptide of GRGDdSP.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number99896-86-3
-
Formula Weight601.61
-
Molecular FormulaC23H39N9O10
-
Purity>98% (HPLC)
-
SolubilityH2O : 50 mg/mL (83.11 mM; ultraphonic) DMSO : 50 mg/mL (83.11 mM; ultraphonic; )
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. G A Gronowicz, et al. Synthetic peptide containing Arg-Gly-Asp inhibits bone formation and resorption in a mineralizing organ culture system of fetal rat parietal bones. J Bone Miner Res. 1994 Feb;9(2):193-201.?
molnova catalog
related products
-
Bufotenine
Bufotenine may have hallucinogenic potential, the presence and levels of bufotenine might be useful and important markers of some psychiatric disorders. Bufotenine is able to block rabies virus infection in BHK-21 cells.
-
3-(3,6-dichloro-9H-c...
3-(3,6-dichloro-9H-carbazol-9-yl)propanoic acid is a compound used as a molecular building block.
-
ELOVL1-IN-2
ELOVL1-IN-2, a compound known as an inhibitor of the elongation of very long chain fatty acid 1 (ELOVL1) enzyme, exhibits a weak inhibitory effect on ELOVL1 (with an IC50 of 21 μM) and demonstrates moderate potency in a primary cellular assay conducted on HEK293 C26 cells (with an IC50 of 6.7 μM) .
